tiprankstipranks
Trending News
More News >
Luye Pharma Group Ltd. (LYPHF)
OTHER OTC:LYPHF
US Market

Luye Pharma Group (LYPHF) Income Statement

Compare
3 Followers

Luye Pharma Group Income Statement

Last quarter (Q4 2024), Luye Pharma Group's total revenue was ¥2.99B, a decrease of -4.60% from the same quarter last year. In Q4, Luye Pharma Group's net income was ¥84.05M. See Luye Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 6.06B¥ 6.14B¥ 5.98B¥ 5.20B¥ 5.54B
Gross Profit
¥ 4.04B¥ 4.20B¥ 4.14B¥ 3.40B¥ 3.99B
Operating Expenses
¥ 2.75B¥ 3.29B¥ 3.19B¥ 3.11B¥ 2.78B
Depreciation and Amortization
¥ 665.47M¥ 701.85M¥ 671.31M¥ 581.98M¥ 510.90M
EBITDA
¥ 1.79B¥ 2.08B¥ 1.81B¥ 906.88M¥ 1.88B
Operating Income
¥ 1.15B¥ 887.44M¥ 1.21B¥ 386.99M¥ 1.42B
Other Income/Expenses
¥ -308.03M¥ -187.34M¥ -210.86M¥ -512.52M¥ -476.78M
Pretax Income
¥ 839.22M¥ 700.10M¥ 669.76M¥ -74.56M¥ 942.17M
Net Income
¥ 471.89M¥ 532.61M¥ 604.81M¥ -144.78M¥ 706.59M
Per Share Metrics
Basic EPS
¥ 0.13¥ 0.14¥ 0.17¥ -0.04¥ 0.22
Diluted EPS
¥ 0.13¥ 0.14¥ 0.17¥ -0.04¥ 0.22
Weighted Average Shares Outstanding
3.76B 3.73B 3.48B 3.45B 3.19B
Weighted Average Shares Outstanding (Diluted)
3.76B 3.73B 3.48B 3.45B 3.19B
Currency in CNY

Luye Pharma Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis